Leslie L. Sharp

4.1k total citations · 1 hit paper
30 papers, 3.4k citations indexed

About

Leslie L. Sharp is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Leslie L. Sharp has authored 30 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 11 papers in Oncology and 7 papers in Genetics. Recurrent topics in Leslie L. Sharp's work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (8 papers). Leslie L. Sharp is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (8 papers). Leslie L. Sharp collaborates with scholars based in United States, Australia and United Kingdom. Leslie L. Sharp's co-authors include Richard D. Huhn, Babak Saboury, Wendy L. Havran, E. Gabriela Chiorean, Wenru Song, Gregory L. Beatty, Weijing Sun, Ursina Teitelbaum, Drew A. Torigian and Peter J. O’Dwyer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Leslie L. Sharp

30 papers receiving 3.3k citations

Hit Papers

CD40 Agonists Alter Tumor Stroma and Show Efficacy Agains... 2011 2026 2016 2021 2011 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie L. Sharp United States 17 2.0k 1.5k 973 291 216 30 3.4k
Marı́a L. Toribio Spain 34 2.1k 1.0× 718 0.5× 1.0k 1.1× 253 0.9× 187 0.9× 109 3.5k
Tapan K. Bera United States 34 1.0k 0.5× 1.0k 0.7× 1.5k 1.5× 340 1.2× 258 1.2× 87 3.6k
Lucia Gabriele Italy 35 2.5k 1.3× 1.5k 1.0× 1.1k 1.1× 225 0.8× 363 1.7× 74 4.3k
Nicolai S. C. van Oers United States 35 3.1k 1.5× 922 0.6× 1.4k 1.5× 215 0.7× 249 1.2× 81 4.4k
Jacques A. Nunès France 27 2.3k 1.1× 971 0.7× 1.0k 1.0× 116 0.4× 239 1.1× 76 3.4k
Lea Eisenbach Israel 33 2.5k 1.2× 1.5k 1.0× 2.1k 2.2× 570 2.0× 347 1.6× 123 4.4k
Shigeki Shichijo Japan 31 1.9k 1.0× 1.1k 0.7× 1.5k 1.6× 127 0.4× 159 0.7× 149 3.2k
Nicolas Reymond France 18 1.3k 0.6× 902 0.6× 1.1k 1.2× 152 0.5× 336 1.6× 22 2.9k
Naoto Hirano Canada 31 2.1k 1.0× 1.9k 1.3× 1.7k 1.8× 525 1.8× 204 0.9× 87 4.4k
Seng‐Ryong Woo United States 16 4.5k 2.2× 2.2k 1.5× 1.9k 1.9× 246 0.8× 407 1.9× 23 5.6k

Countries citing papers authored by Leslie L. Sharp

Since Specialization
Citations

This map shows the geographic impact of Leslie L. Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie L. Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie L. Sharp more than expected).

Fields of papers citing papers by Leslie L. Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie L. Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie L. Sharp. The network helps show where Leslie L. Sharp may publish in the future.

Co-authorship network of co-authors of Leslie L. Sharp

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie L. Sharp. A scholar is included among the top collaborators of Leslie L. Sharp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie L. Sharp. Leslie L. Sharp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matos, Ana Lemos de, et al.. (2022). Abstract 5618: Multi-armed myxoma virus has therapeutic potential for treatment of multiple myeloma. Cancer Research. 82(12_Supplement). 5618–5618. 1 indexed citations
2.
Sharp, Leslie L., Cathy Chang, Gerhard Frey, et al.. (2018). Abstract 827: Anti-tumor efficacy of BA3011, a novel Conditionally Active Biologic (CAB) anti-AXL-ADC. Cancer Research. 78(13_Supplement). 827–827. 16 indexed citations
3.
Rodón, Jordi, Matthew H. Taylor, Eileen M. O’Reilly, et al.. (2018). A phase 1/2 dose-escalation and expansion study of a conditionally active anti-AXL humanized monoclonal antibody (BA3011) in patients with advanced solid tumors.. Journal of Clinical Oncology. 36(15_suppl). TPS12126–TPS12126. 14 indexed citations
4.
Sackley, Catherine, Marion Walker, Christopher R Burton, et al.. (2015). An occupational therapy intervention for residents with stroke related disabilities in UK care homes (OTCH): cluster randomised controlled trial. BMJ. 350(feb05 23). h468–h468. 40 indexed citations
5.
Westwood, Jennifer A., Geoffrey M. Matthews, Jake Shortt, et al.. (2014). Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancers. Leukemia Research. 38(8). 948–954. 14 indexed citations
6.
Escuin-Ordinas, Helena, Mark Elliott, Mohammad Atefi, et al.. (2013). PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody. Journal for ImmunoTherapy of Cancer. 1(1). 14–14. 14 indexed citations
7.
Verbrugge, Inge, Jim Hagekyriakou, Leslie L. Sharp, et al.. (2012). Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies. Cancer Research. 72(13). 3163–3174. 222 indexed citations
8.
Fisher, Timothy S., Cris Kamperschroer, Theodore Oliphant, et al.. (2012). Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity. Cancer Immunology Immunotherapy. 61(10). 1721–1733. 110 indexed citations
9.
Broussard, Christine, Christine Fleischacker, Reiko Horai, et al.. (2006). Altered Development of CD8+ T Cell Lineages in Mice Deficient for the Tec Kinases Itk and Rlk. Immunity. 25(5). 849–849. 7 indexed citations
10.
Broussard, Christine, Reiko Horai, Ana M. Venegas, et al.. (2006). Altered Development of CD8+ T Cell Lineages in Mice Deficient for the Tec Kinases Itk and Rlk. Immunity. 25(1). 93–104. 158 indexed citations
11.
McGargill, Maureen A., Leslie L. Sharp, Jack D. Bui, Stephen Μ. Hedrick, & Sébastien Calbo. (2005). Active Ca2+/Calmodulin-Dependent Protein Kinase IIγB Impairs Positive Selection of T Cells by Modulating TCR Signaling. The Journal of Immunology. 175(2). 656–664. 24 indexed citations
12.
Sharp, Leslie L., Julie Jameson, Deborah A. Witherden, H. Kiyomi Komori, & Wendy L. Havran. (2005). Dendritic Epidermal T-Cell Activation. Critical Reviews in Immunology. 25(1). 1–18. 22 indexed citations
13.
Sharp, Leslie L., Julie Jameson, Gabrielle Cauvi, & Wendy L. Havran. (2004). Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1. Nature Immunology. 6(1). 73–79. 210 indexed citations
14.
Yui, Mary A., Leslie L. Sharp, Wendy L. Havran, & Ellen V. Rothenberg. (2004). Preferential Activation of an IL-2 Regulatory Sequence Transgene in TCRγδ and NKT Cells: Subset-Specific Differences in IL-2 Regulation. The Journal of Immunology. 172(8). 4691–4699. 57 indexed citations
15.
Sharp, Leslie L. & Stephen Μ. Hedrick. (1999). Commitment to the CD4 Lineage Mediated by Extracellular Signal-Related Kinase Mitogen-Activated Protein Kinase and Lck Signaling. The Journal of Immunology. 163(12). 6598–6605. 46 indexed citations
16.
Hedrick, Stephen Μ., et al.. (1998). T‐cell fate. Immunological Reviews. 165(1). 95–110. 14 indexed citations
17.
Bain, Gretchen, Isaac Engel, Hein P. J. te Riele, et al.. (1997). E2A Deficiency Leads to Abnormalities in αβ T-Cell Development and to Rapid Development of T-Cell Lymphomas. Molecular and Cellular Biology. 17(8). 4782–4791. 345 indexed citations
18.
Sharp, Leslie L., David Schwarz, Cynthia M. Bott, Christopher J. Marshall, & Stephen Μ. Hedrick. (1997). The Influence of the MAPK Pathway on T Cell Lineage Commitment. Immunity. 7(5). 609–618. 201 indexed citations
19.
Sharp, Leslie L., Jiadong Zhou, & David F. Blair. (1995). Tryptophan-scanning mutagenesis of MotB, an integral membrane protein essential for flagellar rotation in Escherichia coli. Biochemistry. 34(28). 9166–9171. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026